AAPL349.18+5.35 (+1.56%) ▲|ABBV288.90+2.91 (+1.02%) ▲|ABT104.40+1.76 (+1.71%) ▲|ACN242.99-0.41 (-0.17%) ▼|ADBE246.45-3.31 (-1.33%) ▼|AMAT424.03+8.03 (+1.93%) ▲|AMD569.90-8.54 (-1.48%) ▼|AMGN458.24+6.41 (+1.42%) ▲|AMT184.31+0.56 (+0.30%) ▲|AMZN246.11-8.50 (-3.34%) ▼|AVGO344.50-7.31 (-2.08%) ▼|AXP324.21+6.27 (+1.97%) ▲|BA173.94+6.80 (+4.07%) ▲|BAC51.73+0.88 (+1.73%) ▲|BKNG150.18+2.24 (+1.51%) ▲|BLK1,171.22+13.34 (+1.15%) ▲|BMY60.68+0.11 (+0.17%) ▲|BNY149.96+1.37 (+0.92%) ▲|BRK-B543.61+3.27 (+0.61%) ▲|C126.42+2.31 (+1.86%) ▲|CAT656.78-56.60 (-7.93%) ▼|CL92.35+0.66 (+0.72%) ▲|CMCSA21.98+0.41 (+1.90%) ▲|COF208.78+3.90 (+1.90%) ▲|COP149.24+0.18 (+0.12%) ▲|COST989.27+6.54 (+0.67%) ▲|CRM231.59-10.52 (-4.35%) ▼|CSCO109.12-1.17 (-1.06%) ▼|CVS90.59+0.64 (+0.71%) ▲|CVX230.10+0.90 (+0.39%) ▲|DE659.11+18.44 (+2.88%) ▲|DHR236.92+2.85 (+1.22%) ▲|DIS110.76+1.72 (+1.57%) ▲|DUK125.60+2.03 (+1.64%) ▲|EMR170.71+3.00 (+1.79%) ▲|FDX308.94+4.36 (+1.43%) ▲|GD369.13+14.78 (+4.17%) ▲|GE312.18+11.05 (+3.67%) ▲|GEV904.82+26.79 (+3.05%) ▲|GILD161.15+1.95 (+1.22%) ▲|GM85.76+3.28 (+3.98%) ▲|GOOG283.17-38.72 (-12.03%) ▼|GOOGL285.10-39.80 (-12.25%) ▼|GS934.68+9.51 (+1.03%) ▲|HD325.65+8.09 (+2.55%) ▲|HON221.15+1.89 (+0.86%) ▲|IBM254.77+1.55 (+0.61%) ▲|INTC92.46-3.07 (-3.21%) ▼|INTU330.00+1.81 (+0.55%) ▲|ISRG447.80+3.62 (+0.82%) ▲|JNJ274.90+3.86 (+1.42%) ▲|JPM344.08+4.78 (+1.41%) ▲|KO92.30+0.57 (+0.62%) ▲|LIN499.84-8.32 (-1.64%) ▼|LLY1,371.02+82.72 (+6.42%) ▲|LMT646.44+16.69 (+2.65%) ▲|LOW204.43+6.03 (+3.04%) ▲|LRCX257.50+3.68 (+1.45%) ▲|MA635.83+25.52 (+4.18%) ▲|MCD255.36+4.86 (+1.94%) ▲|MDLZ62.09+0.22 (+0.36%) ▲|MDT96.78+2.00 (+2.11%) ▲|META629.89+17.40 (+2.84%) ▲|MMM176.37+3.57 (+2.07%) ▲|MO75.57+2.58 (+3.53%) ▲|MRK147.55+6.62 (+4.70%) ▲|MS192.58+2.45 (+1.29%) ▲|MSFT524.03-6.99 (-1.32%) ▼|MU945.99-37.24 (-3.79%) ▼|NEE82.20+1.18 (+1.46%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.39+1.24 (+3.32%) ▲|NOW112.01-38.12 (-25.39%) ▼|NVDA213.52-1.87 (-0.87%) ▼|ORCL139.64-4.91 (-3.39%) ▼|PEP132.93+0.30 (+0.23%) ▲|PFE29.73+0.28 (+0.94%) ▲|PG159.01+0.75 (+0.47%) ▲|PLTR194.55-2.27 (-1.15%) ▼|PM205.74+3.10 (+1.53%) ▲|QCOM183.24+0.27 (+0.15%) ▲|RTX200.65+4.81 (+2.45%) ▲|SBUX104.56+1.36 (+1.32%) ▲|SCHW89.72+0.96 (+1.08%) ▲|SO93.07+1.55 (+1.69%) ▲|SPG214.71+3.47 (+1.64%) ▲|T21.03+0.33 (+1.59%) ▲|TMO709.33+5.18 (+0.74%) ▲|TMUS148.77+0.69 (+0.47%) ▲|TSLA405.89+1.67 (+0.41%) ▲|TXN309.48-0.35 (-0.11%) ▼|UBER65.29+0.02 (+0.02%) ▲|UNH405.79-1.31 (-0.32%) ▼|UNP299.08+1.28 (+0.43%) ▲|UPS106.50+0.88 (+0.83%) ▲|USB60.65+1.05 (+1.76%) ▲|V409.94+9.34 (+2.33%) ▲|VZ43.70+0.52 (+1.19%) ▲|WFC85.09+1.42 (+1.69%) ▲|WMT121.05+2.28 (+1.92%) ▲|XOM182.01-0.01 (-0.01%) ▼|AAPL349.18+5.35 (+1.56%) ▲|ABBV288.90+2.91 (+1.02%) ▲|ABT104.40+1.76 (+1.71%) ▲|ACN242.99-0.41 (-0.17%) ▼|ADBE246.45-3.31 (-1.33%) ▼|AMAT424.03+8.03 (+1.93%) ▲|AMD569.90-8.54 (-1.48%) ▼|AMGN458.24+6.41 (+1.42%) ▲|AMT184.31+0.56 (+0.30%) ▲|AMZN246.11-8.50 (-3.34%) ▼|AVGO344.50-7.31 (-2.08%) ▼|AXP324.21+6.27 (+1.97%) ▲|BA173.94+6.80 (+4.07%) ▲|BAC51.73+0.88 (+1.73%) ▲|BKNG150.18+2.24 (+1.51%) ▲|BLK1,171.22+13.34 (+1.15%) ▲|BMY60.68+0.11 (+0.17%) ▲|BNY149.96+1.37 (+0.92%) ▲|BRK-B543.61+3.27 (+0.61%) ▲|C126.42+2.31 (+1.86%) ▲|CAT656.78-56.60 (-7.93%) ▼|CL92.35+0.66 (+0.72%) ▲|CMCSA21.98+0.41 (+1.90%) ▲|COF208.78+3.90 (+1.90%) ▲|COP149.24+0.18 (+0.12%) ▲|COST989.27+6.54 (+0.67%) ▲|CRM231.59-10.52 (-4.35%) ▼|CSCO109.12-1.17 (-1.06%) ▼|CVS90.59+0.64 (+0.71%) ▲|CVX230.10+0.90 (+0.39%) ▲|DE659.11+18.44 (+2.88%) ▲|DHR236.92+2.85 (+1.22%) ▲|DIS110.76+1.72 (+1.57%) ▲|DUK125.60+2.03 (+1.64%) ▲|EMR170.71+3.00 (+1.79%) ▲|FDX308.94+4.36 (+1.43%) ▲|GD369.13+14.78 (+4.17%) ▲|GE312.18+11.05 (+3.67%) ▲|GEV904.82+26.79 (+3.05%) ▲|GILD161.15+1.95 (+1.22%) ▲|GM85.76+3.28 (+3.98%) ▲|GOOG283.17-38.72 (-12.03%) ▼|GOOGL285.10-39.80 (-12.25%) ▼|GS934.68+9.51 (+1.03%) ▲|HD325.65+8.09 (+2.55%) ▲|HON221.15+1.89 (+0.86%) ▲|IBM254.77+1.55 (+0.61%) ▲|INTC92.46-3.07 (-3.21%) ▼|INTU330.00+1.81 (+0.55%) ▲|ISRG447.80+3.62 (+0.82%) ▲|JNJ274.90+3.86 (+1.42%) ▲|JPM344.08+4.78 (+1.41%) ▲|KO92.30+0.57 (+0.62%) ▲|LIN499.84-8.32 (-1.64%) ▼|LLY1,371.02+82.72 (+6.42%) ▲|LMT646.44+16.69 (+2.65%) ▲|LOW204.43+6.03 (+3.04%) ▲|LRCX257.50+3.68 (+1.45%) ▲|MA635.83+25.52 (+4.18%) ▲|MCD255.36+4.86 (+1.94%) ▲|MDLZ62.09+0.22 (+0.36%) ▲|MDT96.78+2.00 (+2.11%) ▲|META629.89+17.40 (+2.84%) ▲|MMM176.37+3.57 (+2.07%) ▲|MO75.57+2.58 (+3.53%) ▲|MRK147.55+6.62 (+4.70%) ▲|MS192.58+2.45 (+1.29%) ▲|MSFT524.03-6.99 (-1.32%) ▼|MU945.99-37.24 (-3.79%) ▼|NEE82.20+1.18 (+1.46%) ▲|NFLX62.09+0.10 (+0.15%) ▲|NKE38.39+1.24 (+3.32%) ▲|NOW112.01-38.12 (-25.39%) ▼|NVDA213.52-1.87 (-0.87%) ▼|ORCL139.64-4.91 (-3.39%) ▼|PEP132.93+0.30 (+0.23%) ▲|PFE29.73+0.28 (+0.94%) ▲|PG159.01+0.75 (+0.47%) ▲|PLTR194.55-2.27 (-1.15%) ▼|PM205.74+3.10 (+1.53%) ▲|QCOM183.24+0.27 (+0.15%) ▲|RTX200.65+4.81 (+2.45%) ▲|SBUX104.56+1.36 (+1.32%) ▲|SCHW89.72+0.96 (+1.08%) ▲|SO93.07+1.55 (+1.69%) ▲|SPG214.71+3.47 (+1.64%) ▲|T21.03+0.33 (+1.59%) ▲|TMO709.33+5.18 (+0.74%) ▲|TMUS148.77+0.69 (+0.47%) ▲|TSLA405.89+1.67 (+0.41%) ▲|TXN309.48-0.35 (-0.11%) ▼|UBER65.29+0.02 (+0.02%) ▲|UNH405.79-1.31 (-0.32%) ▼|UNP299.08+1.28 (+0.43%) ▲|UPS106.50+0.88 (+0.83%) ▲|USB60.65+1.05 (+1.76%) ▲|V409.94+9.34 (+2.33%) ▲|VZ43.70+0.52 (+1.19%) ▲|WFC85.09+1.42 (+1.69%) ▲|WMT121.05+2.28 (+1.92%) ▲|XOM182.01-0.01 (-0.01%) ▼|
17.5 C
New York
Thursday, October 29, 2026

Tag: function

newsFORsourcecompanycontentinformationreleases1market

Emma Daily Digestive Supplement Releases 2025 Update on Methane-Producing Gut Bacteria and Microbiome Imbalance

In this 2025 ingredient transparency update, Emma highlights growing public interest in methane-producing gut bacteria, microbiome imbalance, and non-clinical digestive support. The release explores how plant-based formulations may help support intestinal motility, microbial balance, and daily bowel regularity without relying on probiotics or synthetic cleanses. 
In this 2025 ingredient transparency update, Emma highlights growing public interest in methane-producing gut bacteria, microbiome imbalance, and non-clinical digestive support. The release explores how plant-based formulations may help support intestinal motility, microbial balance, and daily bowel regularity without relying on probiotics or synthetic cleanses.

Native Hydrate Variety Pack Delivers Sugar-Free Hydration with Full Electrolyte Profile and Nine Essential Amino Acids

Clean-label hydration meets real-world functionality in NativePath’s new stick pack assortment featuring natural flavors, third-party tested ingredients, and a complete hydration matrix designed for daily wellness. 
Clean-label hydration meets real-world functionality in NativePath’s new stick pack assortment featuring natural flavors, third-party tested ingredients, and a complete hydration matrix designed for daily wellness.

Native Creatine Responds to 2025 Surge in Creatine Interest Among Women Over 50 Seeking Non-Gym Solutions

NativePath’s Clean-Label Creatine Powder Combines L-Leucine, L-Carnitine, and Creatine Monohydrate for Daily Muscle and Energy Support Without Resistance Training 
NativePath’s Clean-Label Creatine Powder Combines L-Leucine, L-Carnitine, and Creatine Monohydrate for Daily Muscle and Energy Support Without Resistance Training

Toyota Provides $600,000 for Texas Flood Relief

PLANO, Texas, July 8, 2025 /PRNewswire-HISPANIC PR WIRE/ - Toyota Motor North America (TMNA) is partnering with Toyota Financial Services (TFS), Gulf States Toyota...

Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions — Including in Space

QUEENS, N.Y., July 8, 2025 /PRNewswire/ -- Biotia, a biotechnology company pioneering the development of novel infectious disease diagnostics, today announced its selection as...

GW Instek Unveils Full Smart Measurement Portfolio to Accelerate Next-Gen Industrial Testing

TAIPEI, July 8, 2025 /PRNewswire/ -- In response to the global surge in industrial automation and smart manufacturing, precision data acquisition has become a...

Prime Day’s Dark Horse: DESLOC Smart Lock Starts at Only $29.99 — High-Quality Smart Security, Finally Within Reach

Starting at just $29.99, DESLOC smart locks deliver fingerprint security, durable build, and intuitive access—Prime Day's best value in home protection. SAN FRANCISCO, July 8, 2025...

GW Instek Unveils Full Smart Measurement Portfolio to Accelerate Next-Gen Industrial Testing

TAIPEI, July 8, 2025 /PRNewswire/ -- In response to the global surge in industrial automation and smart manufacturing, precision data acquisition has become a...

BloodVitals Pulse Oximeter 2025 Release Reinforces Pain-Free, Real-Time Monitoring of Blood Vitals with Hospital-Grade Precision at Home

In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings. 
In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy...

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.

BTQ Launches World’s First Quantum Proof-of-Work Simulator, Delivering the First Commercial Demonstration of Quantum Advantage in Blockchain Consensus

BTQ Quantum Proof-of-Work (QPoW) Simulator offers a live, interactive platform to demonstrate quantum-native consensus mechanisms that remain compatible with existing blockchain infrastructure.QPoW delivers measurable...

BTQ Launches World’s First Quantum Proof-of-Work Simulator, Delivering the First Commercial Demonstration of Quantum Advantage in Blockchain Consensus

BTQ Quantum Proof-of-Work (QPoW) Simulator offers a live, interactive platform to demonstrate quantum-native consensus mechanisms that remain compatible with existing blockchain infrastructure.QPoW delivers measurable...

Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data

- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins
- Series B round in planning to support pivotal U.S. trial
- New CEO appointment signals next phase of growth and expansion

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFunction

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers